INDEMNIFICATION AGREEMENTIndemnification Agreement • November 2nd, 2022 • Marizyme Inc • Pharmaceutical preparations • Florida
INDEMNIFICATION AGREEMENT (this “Agreement”) is entered into as of ______, 2022 by and between Marizyme, Inc., a Nevada corporation (the “Company”) and the undersigned, a director and/or an officer of the Company (“Indemnitee”), as applicable.
COMMON STOCK PURCHASE WARRANT MARIZYME, INC.Security Agreement • November 2nd, 2022 • Marizyme Inc • Pharmaceutical preparations • Florida
This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, Rydra Capital Corp., a corporation incorporated pursuant to the laws of British Columbia, Canada, or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date referred to above as the Initial Exercise Date (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on December 21, 2026 (the "Termination Date") but not thereafter, to subscribe for and purchase from Marizyme, Inc., a Nevada corporation (the "Company"), up to 100,000 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
INDEPENDENT DIRECTOR AGREEMENTIndependent Director Agreement • November 2nd, 2022 • Marizyme Inc • Pharmaceutical preparations • Florida
INDEPENDENT DIRECTOR AGREEMENT (this “Agreement”), dated ____________, 2022, by and between Marizyme, Inc., a Nevada corporation (the “Company”), and the undersigned (the “Director”).
MARIZYME, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 2nd, 2022 • Marizyme Inc • Pharmaceutical preparations • New York
WAIVERWaiver • November 2nd, 2022 • Marizyme Inc • Pharmaceutical preparations
This WAIVER (this “Waiver”) is made and entered into as of July 22, 2022 by and between Marizyme, Inc., a Nevada corporation (the “Company”) and Viner Total Investments Fund, an entity (the “Investor”).
Marizyme, Inc. Jupiter, Florida 33458Agreement to Transfer Option and Amendatory Agreement • November 2nd, 2022 • Marizyme Inc • Pharmaceutical preparations • Nevada
On July 19, 2019, Marizyme, Inc. (the “Company”) entered into the Stock Option Agreement (the “Stock Option Agreement”) with you (the “Seller”). Under Section 6 of the Stock Option Agreement, the Option (as defined in the Stock Option Agreement) is not transferable by Seller other than to a designated beneficiary upon Seller’s death or by will or the laws of descent and distribution. Seller and the Company desire that Seller sell and transfer the remaining unexercised rights under the Option (the “Sale”) to the Company or its designees for the aggregate consideration of $100,000 (the “Purchase Price”). In order to permit the Sale, the Company is willing to amend the Option to permit its transfer to the Company’s designees solely to facilitate the Sale.
Limited WAIVER AND CONSENTLimited Waiver and Consent • November 2nd, 2022 • Marizyme Inc • Pharmaceutical preparations
This LIMITED WAIVER AND CONSENT (this “Limited Waiver and Consent”) is made and entered into as of [ ], 2022 by and between Marizyme, Inc., a Nevada corporation (the “Company”) and [ ], an entity (the “Investor”).
WAIVERWaiver • November 2nd, 2022 • Marizyme Inc • Pharmaceutical preparations
This WAIVER (this “Waiver”) is made and entered into as of July 22, 2022 by and between Marizyme, Inc., a Nevada corporation (the “Company”) and Waichun Logistics Technology Limited, an entity (the “Investor”).
